Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (221-230 of 317) with videos related to

Pageof 32
Sort By:
Cancer Treatment Reports|February 1, 1983
Repeated femoral vein cannulation for administration of chemotherapeutic agentsB D Nidus, J L Speyer, J Bottino, et al.
Cancer Treatment Reports|September 1, 1987
Treatment of metastatic malignant melanoma with dacarbazine and cisplatinR Oratz, J L Speyer, M Green, et al.
Cancer Treatment Reports|May 1, 1979
Anthracycline derivatives in new drug development programsM Rozencweig, C De Sloover, D D Von Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinomaH S Hochster, M D Green, J Speyer, et al.
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Brain metastases from choriocarcinoma: two patients illustrating key management issuesT Chen, D Ginosar, M Fink, et al.
Cancer Treatment Reviews|September 1, 1979
Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic typesS M Mikulski, W P McGuire, A C Louie, et al.
Cancer Treatment Reports|February 1, 1978
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescueD D Von Hoff, M Rozencweig, A C Louie, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
m-AMSA: a new anticancer agentM Rozencweig, D D Von Hoff, S S Legha, et al.
Cancer Chemotherapy Reports|August 1, 1972
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studiesF M Muggia, P J Creaven, H H Hansen, et al.
Cancer Treatment and Research|January 1, 1991
ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studiesM D Green, P Alderton, M M Sobol, et al.
Pageof 32

Showing results (221-230 of 317) with videos related to

Sort By:
Pageof 32
Cancer Treatment Reports|February 1, 1983
Repeated femoral vein cannulation for administration of chemotherapeutic agentsB D Nidus, J L Speyer, J Bottino, et al.
Cancer Treatment Reports|September 1, 1987
Treatment of metastatic malignant melanoma with dacarbazine and cisplatinR Oratz, J L Speyer, M Green, et al.
Cancer Treatment Reports|May 1, 1979
Anthracycline derivatives in new drug development programsM Rozencweig, C De Sloover, D D Von Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinomaH S Hochster, M D Green, J Speyer, et al.
Journal of Chemotherapy (Florence, Italy)|July 9, 2008
Brain metastases from choriocarcinoma: two patients illustrating key management issuesT Chen, D Ginosar, M Fink, et al.
Cancer Treatment Reviews|September 1, 1979
Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic typesS M Mikulski, W P McGuire, A C Louie, et al.
Cancer Treatment Reports|February 1, 1978
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescueD D Von Hoff, M Rozencweig, A C Louie, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
m-AMSA: a new anticancer agentM Rozencweig, D D Von Hoff, S S Legha, et al.
Cancer Chemotherapy Reports|August 1, 1972
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studiesF M Muggia, P J Creaven, H H Hansen, et al.
Cancer Treatment and Research|January 1, 1991
ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studiesM D Green, P Alderton, M M Sobol, et al.
Pageof 32